a href"https:www.fiercepharma.compharmaintrabio-scores-aqneursa-expansion-now-first-treatment-globally-rare-ataxia" hreflang"en"IntraBio's Aqneursa scores expansion, now the first treatment for rare ataxiaa
IntraBio's streak of success in the rare neurological category continues, as the drugmaker racks up a second indication for Aqneursa, now the first treatment in the world indicated for a rare ataxia.
Read the full story at Fierce Pharma ↗